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 A number of cancers disseminate first through the lymphatic system, and the presence of 
tumor cells in the sentinel or draining lymph node is a major prognostic indicator. Head and neck 
cancers (HNSCC) which preferentially migrate through lymphatics remain one of the most 
common cancers with an incidence of 600,000 new cases worldwide and a poor prognosis of 5 
years survival. Yet mechanisms that contribute to HNSCC metastasis through lymphatics remain 
very poorly understood. Metastasis to lymph nodes is strongly correlated to morbidity, so further 
investigation into the mechanisms and factors that lead to tumor-lymphatic crosstalk and promote 
lymphatic metastasis is needed. The goal of my research is to characterize the cross talk between 
lymphatic endothelial cells (LECs) and tumor cells and analyze specific chemokines, cytokines, 
and inflammatory genes involved. In addition, we also want to evaluate the tole of EMT associated 
genes in this mechanism. Recently, miRNA have emerged as significant predictors of disease 
outcome and in silico analysis was carried out to determine their role in EMT associated pathways 
in this tumor lymphatic crosstalk. This research will be very valuable for the implementation of 
specific therapeutic strategies that are targeting tumors that metastasize through the lymph node 
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Cancer is currently the second leading cause of death after heart disease. Of all cancer 
diagnosis it is believed that head and neck cancer diagnosis make up about 3% of diagnoses. Head 
and neck cancers are characterized by a primary tumor in the pharynx, larynx, nasopharynx, 
oropharynx, and sinuses [1]. It is estimated that in 2017, 79,970 patients were diagnosed with some 
form of head and neck cancer of which roughly 50% of the patients died [2]. Most patients 
diagnosed with head and neck cancers are diagnosed in later stages when their symptoms are more 
severe. When diagnosed in earlier stages patients can have a survival rate as high as 80%, however 
once the cancer becomes more aggressive locally or begins to metastasis the prognosis lowers to 
a less than 40% survival rate. When cancer metastases to a significantly distal site the chance of 
survival is extremely low [4-5]. Head and neck cancers can present with a variety of symptoms 
and are diagnosed with imaging and biopsies of tumors [3, 4]. As with most cancers tobacco use 
is a large causative agent of head and neck cancers. Other risk factors include age and sex. Men 
have been shown to have an increased risk of developing head and neck cancers, and that there is 
increased incidence with increasing age [2, 3, 5]. The largest sex disparities in cancers include 
esophageal and laryngeal cancers, where men are four times more likely to develop these cancers 
than women [2]. There are multiple treatments for cancer, and the best results are found from 
multiple paired therapies. Many head and neck cancers are treated surgically and with radiation 
therapy, but chemotherapy is also effective [1, 3, 4]. Currently there is a lot of research in the 
molecular mechanisms of head and neck cancer development and metastasis for further targeted 
therapies.  
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Metastasis is the largest prognostic factor for cancer patients. Metastasis occurs when 
tumor cells invade surrounding lymphatic or blood vasculature and migrate to a distal location. 
Once in a different location the cells must invade a surrounding tissue and begin to grow. Tumors 
can then promote lymphangiogenesis for further growth and metastasis[6]. For a cancer cell to 
proliferate and metastasize a cell must evade apoptotic factors and the body’s immune system, and 
changes must occur that allow for invasion. Known factors that can influence a cell’s ability to 
metastasis include inflammation, stress, recruitment of macrophages, hypoxic tumor 
environments, and epithelial-mesenchymal transition (EMT)[6]. While EMT is associated with 
healing, it is now known to be an integral part of metastasis[7, 8]. Tumor cells can preferentially 
metastasis through either the blood or lymphatic vasculature, and while much more research has 
been done with regards to blood vasculature metastasis, it is known that EMT is important in both 
for cell motility [6-8]. In metastasis tumor cells change phenotype after EMT to a mesenchymal 
phenotype to migrate through the blood stream. More research has been done recently into 
lymphatic metastasis which has a distinct disease process different from that of blood vasculature 
metastasis [9]. Prox1 and VEGFC play important regulatory roles in lymphatic cell migration and 
proliferation as opposed to blood endothelial cells [9, 10]. Learning more about lymphatic 
metastasis is important for targeted therapies that do not preferentially metastasis through the 
lymphatics like head and neck cancers.  
Head and neck cancer with secondary metastasis is seen in about 15% of patients. Of the 
total patients with head and neck cancer in a single-patient analysis 15-20% of patients who died 
had metastatic cancer, and the median survival rate after being diagnosed with distally metastatic 
cancer was ± four months[11]. Extensive research has been done into changes in lymphatic 
endothelial cells that allow for tumoral development and in microenvironments that lead to 
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invasion for metastasis. Lymphangiogenesis and angiogenesis have been studied to discern what 
role they play in cancer metastasis. Through the use of Coculturing, PCR, Elisa, Western Blotting, 
Northern Blotting, Boyden Assays, and Seahorse XF Analysis other factors, or chemokines and 
cytokines, both have been determined to play an integral role in head and neck cancer metastasis. 
It is accepted that VEGF, LYVE1, EGFR, TGFB, P13K, MMP-9, CXCR1, and CXCR2 are all 
involved in the lymphatic metastatic pathway[12-17].  
Also common in most tumors is microRNA dysregulation. MicroRNA are small RNA that 
have emerged as significant regulators of different diseases including cancers. miRNA inhibits 
gene expression by suppression of specific mRNA. Different miRNAs are involved in a regulatory 
compacity in pathways important for tumor proliferation, invasion, and migration[13, 18]. 
Research on the role microRNA plays in cancer development and metastasis has increased as it 
has become increasingly clear that it has tremendous potential for therapeutic targeting.  
This thesis will explore mechanisms by which head and neck cancers preferentially 
metastasize through the lymphatic vasculature. The mechanism of metastasis will be investigated 
by looking at various components that are known to contribute to the process of invasion and 
dissemination including inflammation, chemokines and cytokines, and the role of Endothelial 
Mesenchymal Transition (EMT). The goal of my research is to characterize the cross talk between 
lymphatic endothelial cells and tumor cells that takes place for metastasis to occur. Recently 
miRNA have emerged as significant predictors of disease outcome and we have identified by in 
silico analysis several miRNAs that target the specific pathways and chemokines or cytokines 
shown to be dysregulated in this tumor lymphatic crosstalk. Through in silico analysis the miRNA 






Cell Culture Techniques  
Lymphatic endothelial cells (LECs) were cultured in Endothelial Cell Growth Medium 
(EGM) MV2 with 1% Penicillin/Streptomycin and 10% FBS. LECs were passaged every 72 hours 
using HEPES BSS, EDTA, and TNS. FaDu, Detroit 562, and SCC9 cell lines were obtained from 
the American Tissue Culture Collection. SCC9 was cultured in Dulbecco’s Modified Eagle’s 
Medium/Nutrient Mixture F-12 Ham with 100 mM of sodium pyruvate, 400 ng/uL hydrocortisone, 
10% FBS, and 1% Antibiotic-Antimycotic. FaDU and Detroit 652 were cultured in Minimum 
Essential Medium Eagle’s with 10% FBS, and 1% Antibiotic-Antimycotic.  All cancer cell lines 
were passaged with DPBS, without calcium or magnesium, and .25% EDTA. All cells were 
maintained, and passaged separately and incubated in separate incubators both at 37 C with 5% 
CO2. 
Preparation of LEC-Conditioned Medium 
HDLEC conditioned medium (LCM) was prepared by incubating the cells in 5% FBS 
containing EGM MV2 (without supplement mix) for 48h. the medium was then removed, 
centrifuged (1000g, 8 min) and stored frozen at -80°C prior to use. SCC9 conditioned medium 
(TCM) was prepared by incubating the cells with plain EGM MV2 medium for 48h. The medium 
was collected, centrifuged and filter sterilized and stored frozen at -80°C. 5% FBS was added to 
this prior to use.  
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RNA Isolation and RNA Quality Determination  
RNA was isolated from the cell lines following the manufacturer’s instructions using the 
RNAeasy Mini Kit (QIAGEN, Germantown, MD). RNA was then quantified using a NanoDrop, 
Quality of RNA was determined by measuring absorbance at 260/280.  
cDNA Preparation  
1ug of RNA was converted to cDNA by the manufacture instructions using Maxima H 
Minus cDNA Synthesis Master Mix (Thermo Scientific, Waltham, MA). The final cDNA was 
diluted to 5ng/µl.  
Real-Time Polymerase Chain Reaction  
Gene expression was determined by Real-Time Polymerase Chain Reaction (PCR). PCR 
was carried out by SYBR Green Real Time PCR Master Mix (Thermo Scientific, Walthman, MA). 
All primers were purchased from Sigma Aldrich (St. Louis, MO). Ubiquitin was used as the 
housekeeping gene for normalization in analysis of gene expression. The forward primer for 
ubiquitin was 5’ AGTCCCTTCTCGGCGATTCT 3’ and the reverse primer was 5’ 
GCATTGTCAAGTGACGATCACAGC 3’. PCR data was analyzed using a two-way ANOVA on 
GraphPad Prism 7. 
Boyden Culturing, Staining and Imaging 
Cancer cell lines were cultured in a 12-well plate in EGM with 5% FBS. Once these cells 
lines are confluent, 8µM standing Boyden chamber inserts (coated with collagen-50µg/mL) are 
placed in each well and 1X105 cells lymphatic endothelial cells are put in each insert. After 48, the 
inserts were taken out, washed, cells in the bottom were fixed with ice cold methanol and stained 
with 0.5% crystal violet and images were taken using an inverted microscope. The number of cells 
were counted using Image J software..  
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miRNA In-Silico Analysis 
In Silico analysis was performed using miRwalk database version 3.0 
(http://mirwalk.umm.uni-heidelberg.de). miRNA that target the EMT genes was analyzed to 
determine common miRNA and pathways that might be activated by the genes.    
Statistical Analysis 
Data were analyzed with Graph pad prism software using ANOVA followed by Fisher 
LSD or using t-test. Mean values between two groups were compared using the Student’s unpaired 






LECs Show Differential Migration Response to Different HNSCC Lines Indicating Possible 
Differences in Molecular Crosstalk 
It is accepted that there is an attraction between tumor cells and the lymphatic vessel to 
promote tumor cell invasion. Previous data from the lab shows that SCC9 migrate in response to 
LECs and that this migration varies with inflammation. To look at the opposite relationship LEC 
migration in response to the different cancer cell lines. Representative mages take to show the 
different migration of LECs is shown in Figure 1. The migration in response to the different cell 
lines were compared to control migration and shown in Figure 2.  
 
Figure 1. LEC migration in response to different HNSCC lines. Representative images of 
migrated cells (10X). SCC9 cells were grown in 12 well plate and 1X105 LECs were counted and 
Control LEC Migration LEC Migration to Detroit 562 
LEC Migration to FaDu LEC Migration to SCC9 
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put in 0.8micron inserts and allowed to migrate for 24 hours and were pictured using 10X. Number 








Figure 2. Cells that migrated towards the various cancer cells were quantified and plotted. 
Values represent mean ± SEM. *, represent values significantly different p≤0.05 when compared 
control 
Several Cytokines and Chemokines were Found to be Differentially Expressed in the Cancer 
Cells when Stimulated with LEC Conditioned Media 
Several chemokine and cytokines are known to participate in the cross talk between cancer 
cells and lymphatic vessels. However, the detailed mechanisms or the specific chemokines and 
cytokines that mediate thes interactions are not completely understood. To investigate what these 
chemokines and cytokines real time PCR was carried out to assess gene expression level in the 
different cancer cell lines when treated with LEC conditioned media as compared to control. The 
different expression of the chemokines or cytokines tested are shown in Figure 3, Figure 4, and 
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Figure 3. Differential expression of cytokines and chemokines in SCC-9 cells in response to 
LEC-Conditioned Medium. The mRNA levels of chemokines in LCM induced SCC9 cells were 
quantified by real time PCR. Expression of HPRT, CCR1, CCR2, CCR7, CCR8, CXCR1, CXCR3, 
CXCR4, CXCR7 and PDL-1 were quantified and plotted. Ubiquitin was used as a housekeeping 
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Figure 4. Differential expression of cytokines and chemokines in FADU cells in response to 
LEC-Conditioned Medium. The mRNA levels of chemokines in LCM induced FADU cells were 
quantified by real time PCR. Expression of HPRT, CCR1, CCR2, CCR7, CCR8, CXCR1, CXCR3, 
CXCR4, CXCR7 and PDL-1 were quantified and plotted as above. Ubiquitin was used as a 
housekeeping control. Values represent mean ± SEM. *, represent values significantly different 
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Figure 5.  Differential expression of cytokines and chemokines in FADU cells in response to 
LEC-Conditioned Medium. The mRNA levels of chemokines in LCM induced FADU cells were 
quantified by real time PCR. Expression of HPRT, CCR1, CCR2, CCR7, CCR8, CXCR1, CXCR3, 
CXCR4, CXCR7 and PDL-1 were quantified and plotted. Ubiquitin was used as a housekeeping 
control. Values represent mean ± SEM. *, represent values significantly different p≤0.05 when 
compared control. 
Several Genes that are Involved in Endothelial-to Mesenchymal Transition were Found to 
be Differentially Expressed in the Cancer Cells when Stimulated with LEC Conditioned 
Media 
EMT is a transition of epithelial cells a mesenchymal phenotype resulting in polarity 
changes. With the mesenchymal phenotype cells lose their ability to form tight cell junctions 
promoting cancer cell invasion and later dissemination. It is thought that EMT plays a large role 
in lymphatic metastasis so it is expected the EMT related genes will be dysregulated in cancer cells 
in response to cytokines and chemokines produced by LECs. The gene expression of EMT 
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associated genes in cancer cell lines treated with LEC CM as compared to control is shown in 
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Figure 6. Several EMT associated genes were found to be differentially regulated in SCC-9 
cells in response to LEC-Conditioned Medium. The mRNA levels of EMT genes in LCM 
induced SCC-9 cells were quantified by real time PCR. Expression of TWIST1, TWIST2, 
SNAIL2, PTCHF, GLI, MMP2, MMP7, MMP11, MMP12, MMP21 were quantified and plotted. 
Ubiquitin was used as a housekeeping control. Values represent mean ± SEM. **, represent values 
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Figure 7. Several EMT associated genes were found to be differentially regulated in FADU 
cells in response to LEC-Conditioned Medium. The mRNA levels of EMT genes in LCM 
induced FADU cells were quantified by real time PCR. Expression of TWIST1, TWIST2, 
SNAIL2, PTCHF, GLI, MMP2, MMP7, MMP11, MMP12, MMP21 were quantified and plotted. 
Ubiquitin was used as a housekeeping control. Values represent mean ± SEM. **, represent values 
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Figure 8. Several EMT associated genes were found to be differentially regulated in Detroit 
cells in response to LEC-Conditioned Medium. The mRNA levels of EMT genes in LCM 
induced Detroit cells were quantified by real time PCR. Expression of TWIST1, TWIST2, 
SNAIL2, PTCHF, GLI, MMP2, MMP7, MMP11, MMP12, MMP21 were quantified and plotted. 
Ubiquitin was used as a housekeeping control. Values represent mean ± SEM. *, represent values 
significantly different p≤0.05 when compared control. 
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In Scilico Analysis  
 miRNA are small, 18-22 nucleotide long strands of RNA that regulate gene expression. 
miRNA are known to be predictors of disease outcome and can be easily target by overexpression 
or inhibition. To see what miRNA that regulate EMT processes during cancer-lymphatic crosstalk 
in silico analysis was performed on genes of significance. Figure 9 is a map that shows the 













Figure 9. In-Silico analysis of EMT genes associated with lymphatic metastasis shows 























It is evident that specific molecular pathways in the tumor microenvironment potentially 
predispose tumors to enter lymphatics. In response to SCC9 cells LEC cells migrated significantly 
(p<.05) when compared to control. LEC migration however did not increase in response to FaDu 
and Detroit 562 cell lines (p<0.05). This shows that LECs show increased invasion in response to 
head and neck cancer cells but this effect is differential and likely depends on the specific cytokine 
and chemokine mechansisms and molecular crosstalk between the tumor cells and the lymphatic 
endothelium.   
SCC9, FaDu, and Detroit 562 cells treated with LEC conditioned medium expressed 
different levels of cytokines, chemokines, and other molecules when compared to control. One 
gene that showed significant difference in all three cell lines is PDl-1. PDL-1 is thought to be 
involved in cancer cell immune evasion[19]. PDL-1 was increased significantly in SCC9, and was 
significantly decreased in FaDu and Detroit 562 cell lines. Increased PDL-1 expression has been 
shown in oral squamous cell and in non-small cell lung cancers. CXCR3 and CXCR4 are 
significantly increased in SCC9 cells which are chemokines involved in the process of 
inflammation. CXCR3 is involved in the recruitment of activated T-cells, and CXCR4 is associated 
with tumor growth [20, 21]. CXCR4 expression is decreased FaDU cells in response to LEC CM. 
CXCR7 expression is increased in both FaDu and Detroit 562. CXCR7 is a associated with tumor 
prognosis and is increased in various tumors. CCR1 is another chemokine associated with the 
process of inflammation which is decreased in expression in SCC9 and FaDu cell lines. CCR7 is 
involved in the control of the migration of immune cells and was increased in Detroit 562. Finally, 
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HPRT expression is increased in SCC9 and FaDu. HPRT is induced by HIF1a which is associated 
with hypoxia. Hypoxic tumor environments are associated with increased cancer cell invasion and 
dissemination. These results demonstrate the cell lines treated with LEC conditioned media 
express different levels of cytokines, chemokines, and other molecules that assist in cancer 
metastasis.  
Several EMT associated genes are found to be dysregulated when the different cancer cell 
lines are treated with conditioned media. TWIST 1 and MMP7 are significantly differentially 
expressed when compared to control in all cell lines. TWIST 1 is considered a regulator of EMT 
because it is involved in the downregulation of E-cadherin. TWIST 1 is decreased in all three cell 
lines. MMP7 is a protein involved in breakdown of the extracellular matrix, that is increased in all 
three cells lines which may be indicative of increased invasion properties of these cell lines in 
response to LECs. TWIST 2 and SNAIL2 are both significantly increased in SSC9 cells. These 
are both considered EMT regulators like TWIST1 for similar role in E-cadherin expression [22]. 
MMP2, like MMP7, are is involved in extracellular matrix remodeling and is increased in SCC9 
and in Detroit 562. Also included in the MMP family is MMP12 which is increased in FaDu cells 
and decreased in Detroit 562 cells, and MMP11 which is significantly decreased in FaDu cells. In 
EMT the MMP family is typically increased to promote invasion [22]. PTCHF was significantly 
decreased in both FaDu and Detroit 562. PTCHF is a known tumor suppressor.  
In-Silico analysis of the EMT genes that showed differential regulation across multiple 
cancer cell lines such at Patched, TWIST2, SNAIL2, MMP2 and MMP7 were analyzed using 
miRWalk and TargetScan to determine common interacting miRNAs. Our analyses showed the 
interaction with several miRNAs that are known to be involved in EMT or cancer initiating and 
promoting pathways. In particular one miRNA that was found to be associated with several EMT 
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genes was miR-9. This is interesting as earlier miR-9 was found to be involved in both suppression 
of inflammation and activation of lymphangiogenic pathways in the LECs [23]. Several other 
interesting miRNAs were also found that warrant more detailed analysis on their functional effects 
and specific target repression in the LECs or the cancer cells. 
Future plans from this research include delineating specific chemokines and cytokines that 
mediate the tumor-lymphatic cross talk, profiling miRNA that are differently expressed in LECs 
cocultured with the different cell lines, and over-expressing or inhibiting one of the most 






1. Cognetti, D.M., R.S. Weber, and S.Y. Lai, Head and neck cancer: an evolving treatment 
paradigm. Cancer, 2008. 113(7 Suppl): p. 1911-1932. 
 
 
2. Siegel, R.L., K.D. Miller, and A. Jemal, Cancer statistics, 2017. CA: A Cancer Journal 
for Clinicians, 2017. 67(1): p. 7-30. 
 
 
3. Mourad, M., et al., Epidemiological Trends of Head and Neck Cancer in the United 
States: A&#xa0;SEER Population Study. Journal of Oral and Maxillofacial Surgery, 
2017. 75(12): p. 2562-2572. 
 
 
4. Ridge, J.A., et al., Head and neck tumors. 2013. 11. 
 
 
5. Guizard, A.-V.N., et al., Diagnosis and management of head and neck cancers in a high-
incidence area in France: A population-based study. 2017. 96(26): p. e7285. 
 
 
6. Scully, O.J., et al., Breast Cancer Metastasis. 2012. 9(5): p. 311-320. 
 
 
7. Thiery, Jean P. and Chwee T. Lim, Tumor Dissemination: An EMT Affair. Cancer Cell, 
2013. 23(3): p. 272-273. 
 
 
8. Kalluri, R., EMT: When epithelial cells decide to become mesenchymal-like cells. The 
Journal of Clinical Investigation, 2009. 119(6): p. 1417-1419. 
 
 
9. Adams, R.H. and K. Alitalo, Molecular regulation of angiogenesis and 
lymphangiogenesis. Nature Reviews Molecular Cell Biology, 2007. 8: p. 464. 
 
 
10. Cueni, L.N. and M. Detmar, New Insights into the Molecular Control of the Lymphatic 
Vascular System and its Role in Disease. Journal of Investigative Dermatology, 2006. 
126(10): p. 2167-2177. 
 
 





12. Zhang, Z., J.I. Helman, and L.-j. Li, Lymphangiogenesis, lymphatic endothelial cells and 
lymphatic metastasis in head and neck cancer--a review of mechanisms. International 
journal of oral science, 2010. 2(1): p. 5-14. 
 
 
13. Jimenez, L., et al., Mechanisms of Invasion in Head and Neck Cancer. Archives of 
Pathology & Laboratory Medicine, 2015. 139(11): p. 1334-1348. 
 
 
14. Zhuang, Z., et al., Altered phenotype of lymphatic endothelial cells induced by highly 
metastatic OTSCC cells contributed to the lymphatic metastasis of OTSCC cells. Cancer 
Science, 2010. 101(3): p. 686-692. 
 
 
15. Walsh, J.E., et al., Mechanisms of Tumor Growth and Metastasis in Head and Neck 




16. Skobe, M., et al., Induction of tumor lymphangiogenesis by VEGF-C promotes breast 
cancer metastasis. Nature Medicine, 2001. 7: p. 192. 
 
 
17. Wheeler, S.E., et al., Epidermal growth factor receptor variant III mediates head and 
neck cancer cell invasion via STAT3 activation. Oncogene, 2010. 29: p. 5135. 
 
 
18. Macfarlane, L.-A. and P.R. Murphy, MicroRNA: Biogenesis, Function and Role in 
Cancer. Current genomics, 2010. 11(7): p. 537-561. 
 
 
19. Weber, M., et al., PD-L1 expression in tumor tissue and peripheral blood of patients with 
oral squamous cell carcinoma. Oncotarget, 2017. 8(68): p. 112584-112597. 
 
 
20. Abron, J.D., et al., Differential role of CXCR3 in inflammation and colorectal cancer. 
Oncotarget, 2018. 9(25): p. 17928-17936. 
 
 
21. Fulton, A.M., The chemokine receptors CXCR4 and CXCR3 in cancer. Current Oncology 




22. Banyard, J. and D.R. Bielenberg, The role of EMT and MET in cancer dissemination. 
Connective Tissue Research, 2015. 56(5): p. 403-413. 
 
 
23. Chakraborty, S., et al., MicroRNA signature of inflamed lymphatic endothelium and role 
of miR-9 in lymphangiogenesis and inflammation. American journal of physiology. Cell 
physiology, 2015. 309(10): p. C680-C692. 
 
